Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2029

Conditions
Non-small Cell Lung CancerSurgery
Interventions
PROCEDURE

neoadjuvant immuno-chemotherapy and surgery

After enrolled, patients should receive neo-adjuvant immuno-chemotherapy and a re-evaluation will be performed after treatment to decide surgery strategy.

Trial Locations (1)

200025

RECRUITING

Ruijin hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Huadong Hospital

OTHER

collaborator

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

OTHER

lead

Ruijin Hospital

OTHER